La Jolla Pharmaceutical Company Announces Fourth Quarter And Full Year 2014 Financial Results And Corporate Highlights

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported fourth quarter and full year 2014 financial results and highlighted recent corporate progress and near-term milestones.

Help employers find you! Check out all the jobs and post your resume.

Back to news